[1]
“PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience: M.L. Tramontano, M. Coppola, S. Coppola, M. Schiavulli | UOSD Centro Regionale Pediatrico Malattie della Coagulazione, Santobono Pausilipon Children Hospital, AORN, Napoli, Italy”, Bleeding Thromb Vascul Biol, vol. 4, no. s1, Aug. 2025, doi: 10.4081/btvb.2025.324.